While it’s now a top source of biopharmaceutical innovation, we believe China’s biotech sector is still in its early stages.

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

Regarding the distribution of Sentelian 24 counterfeit products online, Dongkuk Pharmaceutical Co. urged consumers to pay ...

After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.

Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...

Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

The FDA approval is based on safety and efficacy demonstrated in the phase 3 ARANOTE trial, which evaluated darolutamide — ...

Cohort 3 demonstrates earlier and deeper responses compared to cohorts 1-2. All three cohorts show separation from placebo ...

Across numerous industries, the customer experience (CX) is considered more important than ever. In fact, 96% of the CX ...

Bristol Myers Squibb leapt into the drug industry’s most intense new rivalry on Monday, signing a deal to potentially spend ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...